Cadila Shares Gain On Completing Phase-II Trials Of Covid-19 Therapy
A pharmacist prepares a free flu shot vaccine at a pharmacy in Miami, U.S. (Photographer: Marco Bello/Bloomberg)

Cadila Shares Gain On Completing Phase-II Trials Of Covid-19 Therapy

Shares of Cadila Healthcare Ltd. pared all of their opening losses to trade higher after the drugmaker said it has successfully completed a study evaluating early safety, efficacy and tolerability ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.